Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis

被引：0

作者：

Guilherme Grossi Lopes Cançado

Cláudia Alves Couto

Debora Raquel Benedita Terrabuio

Eduardo Luiz Rachid Cançado

Cristiane Alves Villela-Nogueira

Maria Lucia Gomes Ferraz

Michelle Harriz Braga

Mateus Jorge Nardelli

Luciana Costa Faria

Nathalia Mota de Faria Gomes

Elze Maria Gomes Oliveira

Vivian Rotman

Maria Beatriz Oliveira

Simone Muniz Carvalho Fernandes da Cunha

Marlone Cunha-Silva

Liliana Sampaio Costa Mendes

Claudia Alexandra Pontes Ivantes

Liana Codes

Valéria Ferreira de Almeida e Borges

Fabio Heleno de Lima Pace

Mario Guimarães Pessoa

Laura Vilar Guedes

Izabelle Venturini Signorelli

Gabriela Perdomo Coral

Cynthia Levy

Paulo Lisboa Bittencourt

机构：

[1] Hospital das Clínicas da Universidade Federal de Minas Gerais,Instituto Alfa de Gastroenterologia

[2] Hospital da Polícia Militar de Minas Gerais,Departamento de Gastroenterologia

[3] Faculdade de Medicina da Universidade de São Paulo,Hospital Universitário Clementino Fraga Filho e Departamento de Clínica Médica da Faculdade de Medicina

[4] Universidade Federal do Rio de Janeiro,Disciplina de Gastroenterologia

[5] Universidade Federal de São Paulo,Hospital Universitário Professor Edgard Santos

[6] Centro Universitário Lusíada - UNILUS,Divisão de Gastroenterologia (Gastrocentro), Faculdade de Ciências Médicas

[7] Ambulatório Municipal de Hepatites Virais de São José dos Campos,Serviço de Gastroenterologia, Hepatologia e Transplante Hepático

[8] Universidade Federal da Bahia,Serviço de Gastroenterologia e Hepatologia

[9] Universidade Estadual de Campinas,Hospital Universitário Cassiano Antônio Moraes

[10] Hospital de Base do Distrito Federal,Division of Digestive Health and Liver Diseases

[11] Hospital Nossa Senhora das Graças,undefined

[12] Hospital Português,undefined

[13] Instituto de Gastroenterologia,undefined

[14] Endoscopia e Proctologia,undefined

[15] Universidade Federal de Uberlândia,undefined

[16] Universidade Federal de Juiz de Fora,undefined

[17] Universidade Federal do Espírito Santo,undefined

[18] Irmandade da Santa Casa de Misericórdia de Porto Alegre,undefined

[19] University of Miami Miller School of Medicine,undefined

[20] Escola Bahiana de Medicina e Saúde Pública,undefined

来源：

Digestive Diseases and Sciences | 2023年 / 68卷

关键词：

Primary biliary cholangitis; Treatment; Second-line therapy; Ursodeoxycholic acid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：514 / 520

页数：6

共 63 条

[1]

Corpechot C(2000)The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology. 32 1196-1199

[2]

Carrat F(2008)Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology. 48 871-877

[3]

Bonnand AM(2019)Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis J Hepatol. 71 357-365

[4]

Corpechot C(2014)Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study Gastroenterology. 147 1338-1349.e5

[5]

Abenavoli L(2004)Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis Hepatol Res. 29 216-222

[6]

Rabahi N(2014)Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid Liver Int. 34 197-203

[7]

Harms MH(2018)A placebo-controlled trial of bezafibrate in primary biliary cholangitis N Engl J Med. 378 2171-2181

[8]

van Buuren HR(2016)A placebo-controlled trial of obeticholic acid in primary biliary cholangitis N Engl J Med. 375 631-643

[9]

Corpechot C(2019)Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study Lancet Gastroenterol Hepatol. 4 445-453

[10]

Lammers WJ(2021)Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis J Hepatol. 75 565-571

← 1 2 3 4 5 6 7 →